$514.20
0.18% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US8835561023
Symbol
TMO

Thermo Fisher Scientific Stock price

$514.20
-40.18 7.25% 1M
-69.85 11.96% 6M
-16.59 3.13% YTD
+24.07 4.91% 1Y
-118.80 18.77% 3Y
+203.60 65.55% 5Y
+386.32 302.10% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.94 0.18%
ISIN
US8835561023
Symbol
TMO
Sector

Key metrics

Market capitalization $196.68b
Enterprise Value $225.45b
P/E (TTM) P/E ratio 32.25
EV/FCF (TTM) EV/FCF 29.00
EV/Sales (TTM) EV/Sales 5.32
P/S ratio (TTM) P/S ratio 4.64
P/B ratio (TTM) P/B ratio 4.01
Dividend yield 0.30%
Last dividend (FY24) $1.56
Revenue growth (TTM) Revenue growth -2.42%
Revenue (TTM) Revenue $42.37b
EBIT (operating result TTM) EBIT $7.38b
Free Cash Flow (TTM) Free Cash Flow $7.78b
Cash position $6.66b
EPS (TTM) EPS $15.95
P/E forward 31.26
P/S forward 4.59
EV/Sales forward 5.26
Short interest 0.77%
Show more

Is Thermo Fisher Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Thermo Fisher Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

31 Analysts have issued a Thermo Fisher Scientific forecast:

26x Buy
84%
5x Hold
16%

Analyst Opinions

31 Analysts have issued a Thermo Fisher Scientific forecast:

Buy
84%
Hold
16%

Financial data from Thermo Fisher Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
42,370 42,370
2% 2%
100%
- Direct Costs 25,523 25,523
4% 4%
60%
16,847 16,847
1% 1%
40%
- Selling and Administrative Expenses 4,924 4,924
5% 5%
12%
- Research and Development Expense 1,343 1,343
4% 4%
3%
10,580 10,580
3% 3%
25%
- Depreciation and Amortization 3,205 3,205
6% 6%
8%
EBIT (Operating Income) EBIT 7,375 7,375
1% 1%
17%
Net Profit 6,135 6,135
3% 3%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Thermo Fisher Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Thermo Fisher Scientific Stock News

Neutral
Seeking Alpha
7 days ago
Thermo Fisher Scientific Inc. (NYSE:TMO ) Wolfe 2024 Healthcare Results Conference November 19, 2024 8:00 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Conference Call Participants Doug Schenkel - Wolfe Research Doug Schenkel All right. Good morning, everybody.
Neutral
Business Wire
11 days ago
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company's existing repurchase authorization, of which $1...
Positive
Seeking Alpha
12 days ago
Thermo Fisher Scientific has strong growth prospects due to easing COVID-19 headwinds, improving Chinese and biotech markets, and favorable funding environments. The company's margins should benefit from volume leverage, cost-saving initiatives, M&A synergies, and favorable price/mix as organic growth improves. TMO's valuation is attractive, trading at a discount to historical averages and peer...
More Thermo Fisher Scientific News

Company Profile

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Head office United States
CEO Marc Casper
Employees 122,000
Founded 1960
Website www.thermofisher.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today